{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:16:04Z","timestamp":1782512164496,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jpba.2024.116578","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:58:46Z","timestamp":1732291126000},"page":"116578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nitrogen dioxide sterilization of a set of five ophthalmic active pharmaceutical ingredients: Impact on impurity profile and content"],"prefix":"10.1016","volume":"254","author":[{"given":"Elias","family":"Vanneste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinten","family":"Speleers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyna","family":"Krupianskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Croonenborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"DeMent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Haghedooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-984X","authenticated-orcid":false,"given":"Ann","family":"Van Schepdael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116578_bib1","unstructured":"GMP Eudralex Volume 4 Annex 1. The Rules Governing Medicinal Products in the European Union. Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use. Annex 1 Manufacture of Sterile Medicinal Products, 2020. \u3008https:\/\/health.ec.europa.eu\/document\/download\/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdf\u3009. (Accessed 23 April 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3855\/jidc.11433","article-title":"Effectiveness of autoclaving in sterilizing reusable medical devices in healthcare facilities","volume":"13","author":"Panta","year":"2019","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.jpba.2024.116578_bib3","unstructured":"European Medicines Agency (EMA), Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container, 2019. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-sterilisation-medicinal-product-active-substance-excipient-primary-container_en.pdf\u3009. (Accessed 29 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2021.109795","article-title":"Irradiation of pharmaceuticals: a literature review","volume":"190","author":"Jacobs","year":"2022","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.jpba.2024.116578_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2174\/1573411016999200617144806","article-title":"Radiation sterilization of antibiotics in solid state","volume":"17","author":"Kili\u0144ska","year":"2021","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116578_bib7","unstructured":"International Organisation for Standardization (ISO), ISO11135:2014. Sterilization of Health-care Products \u2013 Ethylene Oxide \u2013 Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices, 2014."},{"key":"10.1016\/j.jpba.2024.116578_bib8","unstructured":"Sterigenics\u00ae, Ethylene Oxide Sterilization, 2020. \u3008https:\/\/sterigenics.com\/technologies\/ethylene-oxide\/\u3009. (Accessed 31 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajic.2006.10.014","article-title":"Ethylene oxide sterilization of medical devices: a review","volume":"35","author":"Mendes","year":"2007","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.jpba.2024.116578_bib10","unstructured":"W.A. Rutala, D.J. Weber, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities \u2013 Ethylene oxide \u201cgas\u201d sterilization, 2008. \u3008https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/guidelines\/disinfection-guidelines-H.pdf\u3009. (Accessed 31 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4265\/bio.22.1","article-title":"Ethylene oxide gas sterilization of medical devices","volume":"22","author":"Shintani","year":"2017","journal-title":"Biocontrol Sci."},{"key":"10.1016\/j.jpba.2024.116578_bib12","unstructured":"Gamma Industry Processing Alliance, International Irradiation Association (GIPA and IIA), A Comparison of Gamma, E-beam, X-ray and Ethylene Oxide Technologies for the Industrial Sterilization of Medical Devices and Healthcare Products, 2017. \u3008https:\/\/gipalliance.net\/wp-content\/uploads\/2013\/01\/GIPA-WP-GIPA-iia-Sterilization-Modalities-FINAL-Version-2017-October-308772.pdf\u3009. (Accessed 31 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib13","series-title":"Block\u2019s Disinfection, Sterilization, and Preservation","first-page":"726","article-title":"Nitrogen dioxide","author":"Opie","year":"2020"},{"key":"10.1016\/j.jpba.2024.116578_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130043","article-title":"Nitrogen dioxide sterilization in low-resource environments: a feasibility study","volume":"10","author":"Shomali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2024.116578_bib15","article-title":"Sterilizing with nitrogen dioxide","volume":"37","author":"Goulet","year":"2013","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jpba.2024.116578_bib16","unstructured":"Noxilizer\u2122, Overview of the nitrogen dioxide sterilization process, 2012. \u3008https:\/\/cdn.thomasnet.com\/ccp\/30718984\/166233.pdf\u3009. (Accessed 31 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1179\/135100006X116718","article-title":"NO* chemistry: a diversity of targets in the cell","volume":"11","author":"Reiter","year":"2006","journal-title":"Redox Rep."},{"key":"10.1016\/j.jpba.2024.116578_bib18","unstructured":"US Food and Drug Administration, 510(k) Premarket Notification, 2014. \u3008https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K160501\u3009. (Accessed 31 January 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib19","unstructured":"EudraGMDP, 2024. \u3008https:\/\/eudragmdp.ema.europa.eu\/inspections\/gmpc\/searchGMPCompliance.do\u3009. (Accessed 23 April 2024)."},{"key":"10.1016\/j.jpba.2024.116578_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2024.116578_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-7183-1_2","article-title":"Chemical pathways of corticosteroids, industrial synthesis from sapogenins","volume":"1645","author":"Herr\u00e1iz","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2024.116578_bib27","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.xphs.2022.01.020","article-title":"The effect of gamma and ethylene oxide sterilization on a selection of active pharmaceutical ingredients for ophthalmics","volume":"111","author":"Van Cauwenbergh","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116578_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0731-7085(98)00268-4","article-title":"Determination of tetracycline and its major degradation products by liquid chromatography with fluorescence detection","volume":"18","author":"Pena","year":"1998","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:43:26Z","timestamp":1733471006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":22,"alternative-id":["S0731708524006204"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116578","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrogen dioxide sterilization of a set of five ophthalmic active pharmaceutical ingredients: Impact on impurity profile and content","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116578"}}